ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Purple Biotech Ltd

Purple Biotech Ltd (PPBT)

2.4237
-0.0363
(-1.48%)
2.63
0.2063
(8.51%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.4237
Bid
2.35
Ask
2.50
Volume
23,218
2.38 Day's Range 2.52
0.00 52 Week Range 0.00
Market Cap
Previous Close
2.46
Open
2.47
Last Trade
55
@
2.4996
Last Trade Time
Financial Volume
$ 55,976
VWAP
2.4109
Average Volume (3m)
-
Shares Outstanding
2,648,200
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-7.24M

About Purple Biotech Ltd

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24. Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Sector
Pharmaceutical Preparations
Industry
Arrange Trans-freight, Cargo
Headquarters
Rehovot, Center, Isr
Founded
2013
Purple Biotech Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PPBT. The last closing price for Purple Biotech was $2.46. Over the last year, Purple Biotech shares have traded in a share price range of $ 0.00 to $ 0.00.

Purple Biotech currently has 2,648,200 shares outstanding. The market capitalization of Purple Biotech is $6.51 million.

PPBT Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

PPBT - Frequently Asked Questions (FAQ)

What is the current Purple Biotech share price?
The current share price of Purple Biotech is $ 2.4237
How many Purple Biotech shares are in issue?
Purple Biotech has 2,648,200 shares in issue
What is the market cap of Purple Biotech?
The market capitalisation of Purple Biotech is USD 6.51M
What is the 1 year trading range for Purple Biotech share price?
Purple Biotech has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the reporting currency for Purple Biotech?
Purple Biotech reports financial results in USD
What is the latest annual profit for Purple Biotech?
The latest annual profit of Purple Biotech is USD -7.24M
What is the registered address of Purple Biotech?
The registered address for Purple Biotech is 4 OPPENHEIMER STREET, SCIENCE PARK, REHOVOT, CENTER, 7670104
What is the Purple Biotech website address?
The website address for Purple Biotech is www.purple-biotech.com
Which industry sector does Purple Biotech operate in?
Purple Biotech operates in the ARRANGE TRANS-FREIGHT, CARGO sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NWGLNature Wood Group Ltd
$ 5.615
(142.03%)
5.98M
KWEKWESST Micro Systems Inc
$ 11.2296
(94.96%)
37.36M
PTLEPTL Ltd
$ 0.3656
(84.74%)
404.15M
APVOAptevo Therapeutics Inc
$ 5.01
(77.66%)
124.47M
MRINMarin Software Incorporated
$ 1.435
(68.82%)
50.06M
CBIOCrescent Biopharma Inc
$ 14.60
(-71.45%)
97.59k
CEROCERo Therapeutics Holdings Inc
$ 11.5501
(-41.75%)
3.03M
BMEABiomea Fusion Inc
$ 1.90
(-34.48%)
11.66M
PSTVPlus Therapeutics Inc
$ 0.2025
(-34.38%)
23.9M
CONIGraniteShares ETF Trust 2X Short COIN Daily ETF
$ 3.7198
(-32.49%)
21.46M
HCTIHealthcare Triangle Inc
$ 0.0265
(19.91%)
455.2M
PTLEPTL Ltd
$ 0.3656
(84.74%)
404.15M
GNLNGreenlane Holdings Inc
$ 0.01035
(-0.48%)
260.94M
NVDANVIDIA Corporation
$ 145.48
(0.94%)
161.49M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.365
(3.56%)
141.16M

PPBT Discussion

View Posts
PinkPennies PinkPennies 2 months ago
PPBT https://finance.yahoo.com/news/purple-biotech-reports-final-data-110000531.html
๐Ÿ‘๏ธ0
retireat40 retireat40 6 months ago
What a steaming POS. 
๐Ÿ‘๏ธ0
retireat40 retireat40 6 months ago
Good move. This thing is a POS. 
๐Ÿ‘๏ธ0
tedpeele tedpeele 7 months ago
crazy - I guess due to small float. I'm out for now. good day. good luck to you.
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 7 months ago
too many

https://www.nasdaqtrader.com/trader.aspx?id=tradehalts
๐Ÿ‘๏ธ0
tedpeele tedpeele 7 months ago
lots of halting
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 7 months ago
$13's
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 7 months ago
6.27 halted up

$PPBT felt a halt coming pic.twitter.com/FlsAn9ocIU— THE FINAL COUNTDOWN (@THIS_TIME_X) December 2, 2024
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 7 months ago
$PPBT back in for another trade pic.twitter.com/gIxKXIzrFG— THE FINAL COUNTDOWN (@THIS_TIME_X) December 2, 2024
๐Ÿ‘๏ธ0
tw0122 tw0122 7 months ago
Looking good $5s + 50% for this low floater pancreatic cancer phase 2
👍 1
TheFinalCD TheFinalCD 7 months ago
PPBT $PPBT Positive final results from Purple Biotech's phase 2 study of CM24 in second line pancreatic cancer were reported.

More Info: https://t.co/V1VEMOp0Oz $XBI $IBB $XPH $PPH pic.twitter.com/dBs3pkTZPc— Ozmosi (@OzmosiHealth) December 2, 2024

https://dilutiontracker.com/app/search/PPBT?a=dbb88c

https://finviz.com/quote.ashx?t=PPBT&p=d
๐Ÿ‘๏ธ0
tw0122 tw0122 7 months ago
$3.10 down -1% low floater will gain some traction some warrants to watch 
๐Ÿ‘๏ธ0
tw0122 tw0122 7 months ago
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of DeathNovember 04 2024 - 7:50AM


Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today announced it has identified serum CEACAM1 as an additional new potential blood biomarker that may help determine which metastatic pancreatic ductal adenocarcinoma (PDAC) patients are most likely to benefit from treatment with CM24. CM24 is a humanized monoclonal antibody that blocks CEACAM1 binding thereby inhibits its activity.  CEACAM1 is overexpressed on certain tumor cells, immune cells, and neutrophils extracellular traps (NETs).PDAC patients who had pretreatment serum CEACAM1 levels between 6K and 15K pg/mL  demonstrated the best outcomes following treatment with CM24 and nivolumab in combination with irinotecan/fluoropyrimidine based chemotherapy compared to chemotherapy control, with respect to both progression free survival (PFS) (median = 4.6 months, hazard ratio [HR] < 0.1, P = 0.003) and overall survival (OS) with an 79% reduction in risk of death (HR = 0.21, P = 0.04). The median OS improved from 3.6 months with chemotherapy alone to 8.7 months with the combination.Purple Biotechโ€™s randomized Phase 2 study of CM24 in the second line treatment of PDAC has previously identified multiple potential biomarkers including another serum-based marker, myeloperoxidase (MPO), and tumor markers.โ€œAs we look ahead to topline Phase 2 results before the end of the year and anticipate advancing CM24 into further clinical development, the identification of an additional serum biomarker for patient selection is a critical advantage for our future CM24 study and more importantly, potentially for cancer patients in need of better outcomes, particularly for pancreatic cancer,โ€ said Gil Efron, Purple Biotech CEO.
๐Ÿ‘๏ธ0
fwb fwb 8 months ago
Usually in a R/S if a person has Less than 1 share, they are paid in cash.
and they are no longer a shareholder of the company.
That is what happen to many shareholders of ELCO Elcom International, Inc.
๐Ÿ‘๏ธ0
Cosa Cosa 9 months ago
I bought 1 share back in 2021 just to keep track. It is -89%
๐Ÿ‘๏ธ0
glenn1919 glenn1919 12 months ago
PPBT...........................................https://stockcharts.com/h-sc/ui?s=PPBT&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
Boknows34 Boknows34 1 year ago
This thing is coming back to lifeโ€ฆFinally
👍️ 1
Monksdream Monksdream 2 years ago
PPBT under $2
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock